Table 2

Clinical characteristics of elderly patients with type 2 diabetes aged older than 60 years according to the gender-specific quartiles of hand grip strength

Grip strength (kg)
(range)
(mean±SD)
MalesFemales
Q1Q2Q3Q4P valueQ1Q2Q3Q4P value
≤29.329.4–33.833.9–38.3≥38.4≤16.416.5–19.819.9–22.0≥22.1
24.8±3.631.7±1.335.8±1.342.3±3.313.6±2.518.3±1.121.0±0.625.0±2.4
n14715315416877857685
Age (years)75.9±6.671.5±6.668.8±5.467.3±5.0<0.00177.2±7.074.4±6.772.0±6.068.1±6.1<0.001
Duration (years)18.8±10.417.0±8.415.3±9.214.8±7.5<0.00118.8±10.215.4±9.215.3±9.512.7±7.6<0.01
BMI (kg/m2)24.5±3.325.0±3.225.3±3.226.7±3.6<0.00125.0±4.324.8±4.025.7±3.627.0±5.5<0.01
HbA1c (%)7.33±0.867.15±0.997.21±0.787.06±0.63<0.057.24±1.007.24±0.717.27±0.827.23±0.93NS
HbA1c (mmol/mol)56.6±9.454.7±10.855.2±8.553.7±6.9<0.0555.6±10.955.6±7.856.0±9.055.6±10.2NS
Systolic BP (mm Hg)124.1±13.7122.9±13.1123.6±12.4123.6±11.2NS126.0±12.1127.0±14.3124.1±13.4125.3±14.9NS
Serum albumin (g/dL)4.31±0.314.43±0.274.46±0.264.51±0.24<0.0014.32±0.264.41±0.224.49±0.274.49±0.26<0.001
LDL-C (mg/dL)105.6±27.3105.1±27.1100.6±26.7104.2±24.4NS103.5±27.1107.4±32.3103.4±24.5108.2±26.0NS
HDL-C (mg/dL)55.4±14.655.8±17.053.4±13.853.6±13.4NS60.3±14.861.2±16.260.7±11.962.7±16.8NS
eGFR (mL/min/1.73 m2)60.9±19.165.7±16.863.9±16.363.5±12.5NS54.3±20.263.2±14.963.4±17.063.5±20.7<0.01
Albuminuria
(µg/g Cr)
20.1 (7.1–110.5)14.8 (5.5–49.0)13.9 (4.9–53.5)9.2 (4.7–21.7)<0.00124.3 (11.1–89.9)18.7 (9.7–52.0)14.5 (8.2–43.3)14.5 (7.1–28.7)<0.05
Retinopathy (%)30.523.123.515.6<0.00131.523.521.613.2<0.05
Neuropathy (%)57.155.851.635.3<0.00161.643.539.732.1<0.01
CAD (%)6.48.37.86.5NS7.85.92.64.7NS
Stroke (%)16.010.94.51.8<0.0017.82.43.92.4NS
PAD (%)3.86.44.53.6NS7.83.51.32.4NS
  • Data are mean±SD or median (IQR) for continuous variables, and percentage for categorical variables.

  • BMI, body mass index; BP, blood pressure; CAD, coronary artery disease; Cr, creatinine; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NS, not significant; PAD, peripheral artery disease.